Two Sigma Investments’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.03M Sell
110,832
-350,398
-76% -$3.25M ﹤0.01% 2183
2025
Q1
$3.38M Buy
461,230
+208,291
+82% +$1.53M 0.01% 1327
2024
Q4
$2.16M Buy
252,939
+45,518
+22% +$389K ﹤0.01% 1604
2024
Q3
$1.8M Sell
207,421
-328,698
-61% -$2.86M ﹤0.01% 1684
2024
Q2
$3.67M Buy
536,119
+516,706
+2,662% +$3.53M 0.01% 1099
2024
Q1
$177K Sell
19,413
-91,587
-83% -$833K ﹤0.01% 2667
2023
Q4
$495K Sell
111,000
-5,100
-4% -$22.7K ﹤0.01% 2386
2023
Q3
$365K Sell
116,100
-20,200
-15% -$63.4K ﹤0.01% 2340
2023
Q2
$703K Sell
136,300
-187,124
-58% -$966K ﹤0.01% 2091
2023
Q1
$1.7M Buy
323,424
+134,339
+71% +$708K ﹤0.01% 1426
2022
Q4
$531K Sell
189,085
-8,675
-4% -$24.4K ﹤0.01% 1937
2022
Q3
$821K Buy
+197,760
New +$821K ﹤0.01% 1504
2022
Q2
Sell
-483,284
Closed -$2.39M 2751
2022
Q1
$2.39M Buy
483,284
+13,418
+3% +$66.4K 0.01% 1240
2021
Q4
$3.28M Sell
469,866
-425,534
-48% -$2.97M 0.01% 1105
2021
Q3
$8.95M Sell
895,400
-140,645
-14% -$1.41M 0.02% 625
2021
Q2
$14.7M Sell
1,036,045
-132,413
-11% -$1.88M 0.03% 519
2021
Q1
$19.2M Buy
1,168,458
+248,163
+27% +$4.07M 0.05% 387
2020
Q4
$19.1M Buy
920,295
+589,995
+179% +$12.2M 0.05% 351
2020
Q3
$2.51M Buy
330,300
+141,385
+75% +$1.08M 0.01% 841
2020
Q2
$1.57M Buy
188,915
+164,554
+675% +$1.37M 0.01% 972
2020
Q1
$121K Buy
+24,361
New +$121K ﹤0.01% 1705
2019
Q2
Sell
-30,737
Closed -$122K 2317
2019
Q1
$122K Sell
30,737
-39,444
-56% -$157K ﹤0.01% 1984
2018
Q4
$279K Buy
70,181
+51,186
+269% +$203K ﹤0.01% 1771
2018
Q3
$131K Buy
+18,995
New +$131K ﹤0.01% 1904